Astellas Can't Shake MDL Over Generic Prograf Delays
A Massachusetts federal judge on Wednesday refused to dismiss multidistrict antitrust litigation accusing Astellas Pharma US Inc. of keeping a generic version of its immunosuppressant Prograf off the market and forcing...To view the full article, register now.
Already a subscriber? Click here to view full article